
Healthcare Product Manufacturers, Health Service Providers
MedRobot

Lung cancer is the number one cancer killer globally and the largest newly diagnosed and lethal cancer type in China.In recent years, the incidence of lung cancer in China has been continuously increasing., according to WHOGroupData shows that China had about 871,000 new lung cancer cases in 2022.,The mortality rate ranks first among malignant tumors.
Currently, lung nodule biopsy surgery is one of the important methods for the early diagnosis of lung cancer.However, since early-stage pulmonary nodules are usually located deep in the lungs and have a smaller diameter, the difficulty of diagnosis is increased, and existing diagnostic techniques are not able to fully identify them.
# MONARCH® Robotic Assisted Diagnostic and Therapeutic System
Developed by Johnson & JohnsonMONARCH®Diagnostic and Treatment RobotsApplied innovative technologies such as multi-modal fusion navigation based on optical recognition, dynamic electromagnetic guidance, and endoscope motion data, as well as game-style joystick control. Under dual robotic arm control, it can drive a retractable flexible endoscopic channel to reach deep lung lesions and achieve precise manipulation with continuous visual assistance, improving the minimally invasive and precise nature of lung cancer diagnosis and treatment.Of epoch-making significance.

▲MONARCH® Natural Orifice Robotic System for Diagnosis and Treatment
# About Johnson & Johnson


TINAVI | Conorth | Surui | Rosenthal
Aibo Medical Robot | Yuanhua Intelligence | Born思
MicroPort Medical | Jianjia | Minimally Invasive Robot
Sizherui Intelligent Medical| Toda Medical | Changmu Valley
Updates from Other Surgical Robotics Companies:
Progress of Chinese Surgical Robot Companies
Progress of Overseas Surgical Robotics Companies
